Finished
Comparison of Concentration of Vasopressin During Robot-assisted Laparoscopic Myomectomy
NCT04874246 · Seoul National University Hospital · Updated 26 June 2023
- What is being tested
- Vasopressin
- For
- Uterine Leiomyoma
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 19 years to 60 years. About 39 people. The full rules are on the registry page.
- Where
- South Korea
- When
- Starts or started 10 May 2021, ends 31 Dec 2022. Registered 5 May 2021.
- Results
- None posted yet.
In the researchers' words
The purpose of this study is to compare the effect of the concentration of vasopressin, which is used as a method for reducing blood loss in robot-assisted laparoscopic myomectomy.
Sites
- Seoul National University HospitalSeoul, South Korea